Day: October 10, 2022

Vantiva: Information concerning the total number of voting rights and shares

Vantiva: Information concerning the total number of voting rights and shares

October 10th, 2022 Vantiva: Information concerning the total number of voting rights and shares, provided pursuant to Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des marchés financiers Vantiva Shares(ISIN Code FR0013505062) Date Number of Outstanding Shares Number of Voting Rights September 30, 2022   355,343,245   Number of Theoretical Voting Rights(1): 355,343,245 Number of Voting Rights Exercisable at Shareholders’ meeting(2): 355,343,245 (1)    Calculated, pursuant to Article 223-11 of the General Regulations of the Autorité des Marchés Financiers, based on the total number of outstanding shares to which voting rights are attached, including shares with suspended voting rights. (2)    Excluding shares with suspended voting rights. *                ** About...

Continue reading

Zealand Pharma major shareholder announcement: Van Herk Investments

Zealand Pharma major shareholder announcement: Van Herk Investments

Company announcement – No. 46 / 2022 Zealand Pharma major shareholder announcement: Van Herk Investments Copenhagen, Denmark and Boston, MA, 10 October 2022 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces the receipt of notification dated 10 October 2022 pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholders: As from 7 October 2022 Van Herk Investments B.V. (Dutch registration no. 59055057) holds nominally 7,630,244 shares (each share carrying one vote) in Zealand Pharma A/S, corresponding to 14,81% of the total share capital and total voting rights Zealand Pharma A/S. Van Herk Investments B.V. is 100% owned by Van Herk Investments THI B.V....

Continue reading

Smart City Platforms Market to Grow $258.2 Billion By 2026 - Report by MarketsandMarkets™

Smart City Platforms Market to Grow $258.2 Billion By 2026 – Report by MarketsandMarkets™

Chicago, Oct. 10, 2022 (GLOBE NEWSWIRE) — The global Smart City Platforms Market size to grow from USD 156.1 billion in 2021 to USD 258.2 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 10.6 % during the forecast period , according to a new report by MarketsandMarkets™. Various factors such as increase in adoption of IoT technology for infrastructure management and city monitoring and exponential rise in urban population are expected to drive the adoption of smart city platforms solutions and services. Smart city platforms offer a middleware operational capability, wherein multiple software and hardware can be integrated, along with several communication protocols, to deliver latent-free solutions for smart cities. Smart city platforms provide a common level of abstraction and manage information from multiple smart...

Continue reading

Dry Eye Disease Market to Hit sales of $8.21 Billion by 2028 | Allergen, Johnson and Johnson, and Novartis, Takeda, and Sun Pharmaceutical Hold 35% Market Share

Dry Eye Disease Market to Hit sales of $8.21 Billion by 2028 | Allergen, Johnson and Johnson, and Novartis, Takeda, and Sun Pharmaceutical Hold 35% Market Share

Global Dry Eye Disease Market size was valued at US$ 5.95 billion in 2021, and it is expected to reach a value of US$ 8.21 billion by 2028, at a CAGR of more than 4.71% over the forecast period (2022- 2028). Westford,USA, Oct. 10, 2022 (GLOBE NEWSWIRE) — As the population ages, the prevalence of dry eye disease (DED) is expected to increase. As per recent study, the disease affects the around 5.5% to 33% global population every year.  But, it is highly prominent in people above 45% years, especially in women across the Global Dry Eye Disease Market. The condition is already the most common reason for visits to eye care professionals, and this trend is likely to continue as the baby boomer generation enters its golden years. There are a number of factors that contribute to the development of DED, including medications, skin diseases,...

Continue reading

Medical Products Market to Hit Sales $716.28 Billion by 2028 | Trends, Challenges and Opportunity | SkyQuest Technology

Medical Products Market to Hit Sales $716.28 Billion by 2028 | Trends, Challenges and Opportunity | SkyQuest Technology

Global Medical Products Market size was valued at USD 508.2 billion in 2021 and is expected to reach USD 716.28 billion by 2028, growing at a CAGR of 6.76% during the forecast period 2022-2028). Westford,USA, Oct. 10, 2022 (GLOBE NEWSWIRE) — Global Medical Products Market is highly competitive, with a large number of small and medium-sized companies vying for market share. In order to succeed, companies need to focus on product innovation and providing value to their customers. They also need to have a clear understanding of the regulatory landscape and be able to navigate the complex approval process for new products. According to SkyQuest, the top 10 medical product manufacturing companies in global medical products market are Johnson & Johnson, GE Healthcare, Philips, Siemens Healthineers, Medtronic, Abbott Laboratories,...

Continue reading

Boskalis and partners renew Europa Terminal in the port of Antwerp

Boskalis and partners renew Europa Terminal in the port of Antwerp

PSA terminal 4 PSA terminal 4 Papendrecht, 10 October 2022 Boskalis, together with partners Artes Roegiers, Artes Depret and Herbosch-Kiere, will renew the Europa Terminal in Antwerp, Belgium for client Port of Antwerp-Bruges to ensure that the port can continue to receive the largest container ships and increase capacity by a third. The work, which officially commenced last Friday, will take nine years and will be carried out in three phases, taking maximum account of nature and the environment. The project carries a total value of EUR 335 million. Global container congestion calls for more efficient space for handling containers for larger ships. For this reason, the current draft of ships that can moor at the quay wall of the Europa Terminal will be deepened from 13.5 meters to the maximum draft of approximately 16 meters. As the...

Continue reading

REC Silicon - Presentation at the UEDA Conference

REC Silicon – Presentation at the UEDA Conference

October 10, 2022: REC Silicon ASA (REC Silicon) Please find attached the company presentation given by Kurt Levens, REC Silicon CEO, at the UEDA conference in Bozeman, Montana, USA. For further information, please contact: Nils O. Kjerstad IR Contact Phone: +47 9135 6659 Email: nils.kjerstad@crux.no About REC Silicon REC Silicon is a leading producer of advanced silicon materials, delivering high-purity polysilicon and silicon gas to the solar and electronics industries worldwide. We combine 30 years of experience and proprietary technology with the needs of our customers, and annual production capacity of more than 20,000 MT of polysilicon from our two US-based manufacturing plants. Listed on the Oslo Stock Exchange (ticker: REC), the company is headquartered in Fornebu, Norway. For more information, go to: www.recsilicon.com ...

Continue reading

Verizon extends customer offer to Florida counties hardest hit by Hurricane Ian through Oct. 31

Verizon extends customer offer to Florida counties hardest hit by Hurricane Ian through Oct. 31

FORT MYERS, Fla., Oct. 10, 2022 (GLOBE NEWSWIRE) — As residents of Southwest Florida continue to recover, Verizon is extending its support for counties most impacted by Hurricane Ian. Consumer and small business customers* in the following counties will continue to receive unlimited calling, texting and mobile data through October 31, 2022: Charlotte Collier Desoto Hardee Lee Sarasota JetPack data usage will also be waived. Customers do not have to take any action to take advantage of the offer and can verify eligibility for call/text/data relief by entering their zip code here: https://www.verizon.com/featured/relief/. We will continue to monitor and evaluate the counties included in this offer. Verizon also has Wireless Emergency Communication Centers in the area providing charging, free wifi and free portable power packs for...

Continue reading

Form 8 (OPD) Nektar Therapeutics, Inc.

Form 8 (OPD) Nektar Therapeutics, Inc.

FORM 8.3 OPENING DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION       (a) Full name of discloser: Invesco Ltd.   (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.     (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Nektar Therapeutics, Inc.   (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:     (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date...

Continue reading

Form 8 (OPD) PureTech Health PLC

Form 8 (OPD) PureTech Health PLC

FORM 8.3 OPENING DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION       (a) Full name of discloser: Invesco Ltd.   (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.     (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree PureTech Health PLC   (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:     (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.